JPS6331444B2 - - Google Patents

Info

Publication number
JPS6331444B2
JPS6331444B2 JP4654683A JP4654683A JPS6331444B2 JP S6331444 B2 JPS6331444 B2 JP S6331444B2 JP 4654683 A JP4654683 A JP 4654683A JP 4654683 A JP4654683 A JP 4654683A JP S6331444 B2 JPS6331444 B2 JP S6331444B2
Authority
JP
Japan
Prior art keywords
group
furyl
oxazolyl
compound
nax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4654683A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59172488A (ja
Inventor
Kazuo Matsumoto
Koki Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP4654683A priority Critical patent/JPS59172488A/ja
Publication of JPS59172488A publication Critical patent/JPS59172488A/ja
Publication of JPS6331444B2 publication Critical patent/JPS6331444B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4654683A 1983-03-18 1983-03-18 抗脂血剤 Granted JPS59172488A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4654683A JPS59172488A (ja) 1983-03-18 1983-03-18 抗脂血剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4654683A JPS59172488A (ja) 1983-03-18 1983-03-18 抗脂血剤

Publications (2)

Publication Number Publication Date
JPS59172488A JPS59172488A (ja) 1984-09-29
JPS6331444B2 true JPS6331444B2 (enrdf_load_html_response) 1988-06-23

Family

ID=12750303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4654683A Granted JPS59172488A (ja) 1983-03-18 1983-03-18 抗脂血剤

Country Status (1)

Country Link
JP (1) JPS59172488A (enrdf_load_html_response)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158168A0 (en) * 2001-04-16 2004-03-28 Tanabe Seiyaku Co 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
JPS59172488A (ja) 1984-09-29

Similar Documents

Publication Publication Date Title
EP1419770A1 (en) Apo ai expression accelerating agent
JPH0471073B2 (enrdf_load_html_response)
EP0087782B1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
JPS6331444B2 (enrdf_load_html_response)
FR2492378A1 (fr) Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation
WO2019208635A1 (ja) 縮合ピリミジン誘導体
JPS6256152B2 (enrdf_load_html_response)
JPH0357901B2 (enrdf_load_html_response)
JPH0121148B2 (enrdf_load_html_response)
JPH0449B2 (enrdf_load_html_response)
CN111138422B (zh) 一种用于防治红斑狼疮的药物及其制备方法
US4255433A (en) (+)-(3-Methyl-4-oxo-5N-piperidinothiazolidin-2-ylidene)acetic acid esters, method of preparation and use
JPH0449548B2 (enrdf_load_html_response)
JPS60202820A (ja) 抗脂血剤
JPH0499770A (ja) ロダニン誘導体
JP4011780B2 (ja) ジヒドロキノリン誘導体
JPH08501109A (ja) ６−クロロ−５−フルオロ−３−（２−テノイル）−２−オキシンドール−１−カルボキサミドのリジン塩
JP3061446B2 (ja) 血管拡張剤
JPS6134422B2 (enrdf_load_html_response)
JPS62292754A (ja) 安息香酸誘導体
JP2019531348A (ja) アセトフェノン系化合物、その調製方法及び血中脂質調整への使用
JPS629112B2 (enrdf_load_html_response)
JPS58113183A (ja) 環状イミノカルボン酸誘導体およびその塩類
JPH0577651B2 (enrdf_load_html_response)
CS237347B2 (en) Processing of racemic or optically active 5-substituted oxazolidine-2,4-dione